Data availability
DISEASE
Clinical data are available under restricted access for confidentiality reasons; researchers can request access to our studies by providing a scientific research proposal with a commitment to publish their findings. Researchers whose requests are approved by an independent panel and accepted by GSK are provided access to data in a secure environment upon signing a Data Sharing Agreement (DSA). Review criteria for research proposals are: Scientific rationale and relevance of the proposed research to medical science or patient care, ability of the proposed research plan (design, methods and analysis) to meet the scientific objectives, qualifications and experience of the research team to conduct the proposed research review, whether the proposal has potential to produce information that may increase the risk of identification of individual research participants, any real or potential conflicts of interest that may impact the planning, conduct or interpretation of the research and proposals to manage these conflicts of interest, and the publication plan for the research. In addition, patients give permission through an informed consent form to use their data for original studies, so further research must study the medicine or disease that was researched in the original studies. Data will not be provided to requesters where there is a potential conflict of interest, data are to be used for a commercial purpose or there is an actual or potential competitive risk, and researchers are required to sign a DSA, which includes requirements to publish results of the analysis in a scientific journal or pre-print option and open-source release of any software or models. Submitted proposals will be acknowledged within a week and anonymized data will be shared within 30 days of signing the DSA. Access to data and documents is provided for 12 months with the possibility of extension up to an additional 6 months. Please see 